Zombie companies in China in the COVID-19 era

被引:4
|
作者
Zhao, Jingchen [1 ,2 ]
Wei, Chuyi [3 ,4 ]
机构
[1] Guangdong Univ Finance & Econ, Sch Law, Guangzhou, Peoples R China
[2] Nottingham Trent Univ, Nottingham Law Sch, Nottingham, England
[3] Jinan Univ, Sch Law, Guangzhou, Peoples R China
[4] Jinan Univ, Sch Law, Guangzhou 510630, Peoples R China
关键词
D O I
10.1002/iir.1501
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
COVID-19 poses novel sources of uncertainty and risk to companies, but it also offers many opportunities. In the COVID-19 era, unprecedented government and central bank interventions to tackle the economic crisis precipitated by the pandemic have reinvigorated the debate on the threat of a zombification of the economy in China, caused by unviable companies being kept alive artificially. This particular consequence of COVID-19 may aggravate the economic problem of zombie companies in China, increase the risk of further zombification, and create new zombie companies. Recognizing the risk factors of zombie companies and revisiting corporate insolvency law in China, this article aims to address a gap in knowledge related to how zombie companies are being handled in practice in China in the era of the pandemic. In particular, we will investigate the definition, recognition, and uniqueness of zombie companies in the context of COVID-19, and propose several policy actions, primarily through Chinese insolvency law, to mitigate the risk of the return of zombie companies or a further zombification of the economy. It is anticipated that these measures will help to enhance China's sustainable economic recovery in the wake of the COVID-19 pandemic.
引用
收藏
页码:309 / 335
页数:27
相关论文
共 50 条
  • [21] Trucking in the Era of COVID-19
    Sperry, Danielle
    Schuster, Amy M.
    Cotten, Shelia R.
    Agrawal, Shubham
    Mack, Elizabeth
    Britt, Noah
    Liberman, Jessica
    AMERICAN BEHAVIORAL SCIENTIST, 2022,
  • [22] Loneliness in the Era of COVID-19
    Miller, Eric D.
    FRONTIERS IN PSYCHOLOGY, 2020, 11
  • [23] Telemedicine in the Era of COVID-19
    Portnoy, Jay
    Waller, Morgan
    Elliott, Tania
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (05): : 1489 - 1491
  • [24] Adapting in the COVID-19 Era
    Papathanakos, Georgios
    Andrianopoulos, Ioannis
    Papathanasiou, Athanasios
    Lepida, Dimitra
    Koulouras, Vasilios
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 (12) : 1286 - 1287
  • [25] PTSD in the COVID-19 Era
    Chamaa, Farah
    Bahmad, Hisham F.
    Darwish, Batoul
    Kobeissi, Jana M.
    Hoballah, Malak
    Nassif, Sibell Bou
    Ghandour, Yara
    Saliba, Jean-Paul
    Lawand, Nada
    Abou-Kheir, Wassim
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (12) : 2164 - 2179
  • [26] Influenza in the COVID-19 Era
    Solomon, Daniel A.
    Sherman, Amy C.
    Kanjilal, Sanjat
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (13): : 1342 - 1343
  • [27] Misinformation in the COVID-19 era
    Toth, Gabor
    Spiotta, Alejandro M.
    Hirsch, Joshua A.
    Fiorella, David
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2020, 12 (09) : 829 - 830
  • [28] Asthma in the era of COVID-19
    Assaf, Sara
    Stenberg, Henning
    Jesenak, Milos
    Tarasevych, Svitlana P.
    Hanania, Nicola A.
    Diamant, Zuzana
    RESPIRATORY MEDICINE, 2023, 218
  • [29] Universities in the COVID-19 Era
    Journal of the Institute of Electrical Engineers of Japan, 2021, 141 (12):
  • [30] Radiotherapy in the era of COVID-19
    Lancia, Andrea
    Bonzano, Elisabetta
    Bottero, Marta
    Camici, Marta
    Catellani, Francesco
    Ingrosso, Gianluca
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (08) : 625 - 627